Kyle Parker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kyle Parker has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ami Patel
The Wistar Institute, Philadelphia, PA 19104, USA
1 shared publication Ashley S. Tseng
Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, United States
1 shared publicationElaine Bradford
MRIGlobal, Kansas City, MO, United States
1 shared publication- Falgunee K. Parekh
United States
1 shared publication - Gene Garrard Olinger
Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America
1 shared publication - Illich Manfred Mombo
Centre Interdisciplinaire de Recherches Medicales de Franceville, Franceville, Gabon
1 shared publication
Latest Publications
- Open Access
- 26 July 2023
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 4, 1221804
Retrospective on molecular assay design for detecting pan-orthopox viruses and prospective on mpox laboratory preparedness and readiness
The landscape of in vitro diagnostic (IVD) devices encompasses a broad range of tests that have been used to detect and diagnose pathogens, especially tropical diseases, for decades. The COVID-19 pandemic exemplified the greater need for bringing IVDs from the laboratory directly to the consumer, and recent outbreaks such as mpox, Sudan ebolavirus, and Marburg virus further reinforce this need. The increased emergence of tropical disease outbreaks requires more agile development, higher performance, and mass production of IVD devices. Furthermore, lessons learned in previous device developments can sometimes be used to accelerate new disease diagnostic applications. As an example, we describe one case history of an earlier pan-orthopox viral assay that detected smallpox variola and vaccinia strains, and also discerned related strains including mpox. This work established the foundation for the molecular detection of orthopox viruses, which could be mobilized to address public health needs once an emergency declaration was made that opened the FDA pathway for issuing an emergency use authorization for the use of these assays. Thus, the utilization of knowledge from earlier investments was shown to enhance preparedness and readiness. Here in this retrospective, we elaborate on the processes that enable this approach, including multi-disciplinary and multisectoral collaborations to accomplish a holistic, one health world.
- 26 July 2023
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 4, 1221804
Open AccessRetrospective on molecular assay design for detecting pan-orthopox viruses and prospective on mpox laboratory preparedness and readiness
The landscape of in vitro diagnostic (IVD) devices encompasses a broad range of tests that have been used to detect and diagnose pathogens, especially tropical diseases, for decades. The COVID-19 pandemic exemplified the greater need for bringing IVDs from the laboratory directly to the consumer, and recent outbreaks such as mpox, Sudan ebolavirus, and Marburg virus further reinforce this need. The increased emergence of tropical disease outbreaks requires more agile development, higher performance, and mass production of IVD devices. Furthermore, lessons learned in previous device developments can sometimes be used to accelerate new disease diagnostic applications. As an example, we describe one case history of an earlier pan-orthopox viral assay that detected smallpox variola and vaccinia strains, and also discerned related strains including mpox. This work established the foundation for the molecular detection of orthopox viruses, which could be mobilized to address public health needs once an emergency declaration was made that opened the FDA pathway for issuing an emergency use authorization for the use of these assays. Thus, the utilization of knowledge from earlier investments was shown to enhance preparedness and readiness. Here in this retrospective, we elaborate on the processes that enable this approach, including multi-disciplinary and multisectoral collaborations to accomplish a holistic, one health world.